Europe Mammography Market Industry Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The European mammography market represents a significant segment of the broader medical imaging industry, valued at approximately $757 million in 2025. The market covers equipment used for breast cancer detection and diagnosis, including digital mammography systems, analog-to-digital conversion units, and supporting accessories. Demand is sustained by national and regional breast cancer screening programs that serve millions of women across the continent.

• •Market valued at approximately $757 million in 2025 with a compound annual growth rate near 8.7%
• •Equipment portfolio includes full-field digital mammography, computed radiography, and 3D tomosynthesis systems
• •Demand underpinned by population-based screening programs and clinical diagnostic requirements

The principal catalyst for market expansion is the rising incidence of breast cancer across European populations, combined with increasing healthcare expenditure allocated to early detection initiatives. National screening programs in countries such as the United Kingdom, France, and the Netherlands continue to drive equipment procurement cycles, while the replacement of aging analog systems with digital platforms accelerates capital spending. Technological advancements, particularly the integration of artificial intelligence algorithms for lesion detection, are encouraging healthcare providers to upgrade existing infrastructure.

• •Rising breast cancer incidence rates across European populations fuel demand for diagnostic equipment
• •Ongoing national screening mandates and infrastructure upgrades drive recurring procurement cycles
• •AI-assisted detection tools and digital transition encourage replacement of legacy analog systems

The European market is segmented by product type, including digital mammography systems, analog systems, and biopsy devices, as well as by end-user, spanning hospitals, specialty clinics, and diagnostic imaging centers. Germany represents one of the largest national markets and is projected to grow at a notably higher rate of approximately 11.8% through 2030, reflecting strong healthcare investment and population density. Broader European Union markets are tracking CAGR estimates in the 9% to 9.5% range, with country-level screening policies creating variable demand profiles across the region.

• •Germany leads regional growth at approximately 11.8% CAGR, reflecting strong healthcare investment
• •EU-wide market segment accelerating at 9% to 9.5% CAGR, influenced by country-specific screening mandates
• •Market segments by product type (digital, analog, biopsy systems) and end-user (hospitals, clinics, imaging centers)

What are the recent trends and outlook?

The market is expected to sustain its growth trajectory through the end of the decade, with several structural trends shaping its evolution. The adoption of AI-powered screening tools is accelerating as regulatory approvals enable broader clinical deployment, while digital breast tomosynthesis gains market share over conventional 2D mammography. Mobile and portable screening units are expanding access in underserved and rural regions, contributing to more equitable detection rates. Long-term projections suggest the European market could approach or exceed $1 billion in value within the current decade, contingent on continued policy support and technology adoption.

• •AI-assisted detection and digital breast tomosynthesis are rapidly reshaping product demand
• •Mobile screening solutions extend reach into underserved and geographically dispersed populations
• •Projected market value approaching or exceeding $1 billion by 2030 amid sustained policy and technology support